Elevated preoperative neutrophil to lymphocyte ratio predicts risk of recurrence following curative resection for stage IIA colon cancer

International Journal of Colorectal Disease

Volumn 25, Issue 12, 2010, Pages 1427-1433

  Ding, Pei Rong ^a,b   An, Xin ^a   Zhang, Rong Xin ^a,b   Fang, Yu Jing ^a,b   Li, Li Ren ^a,b   Chen, Gong ^a,b   Wu, Xiao Jun ^a,b   Lu, Zhen Hai ^a,b   Lin, Jun Zhong ^a,b   Kong, Ling Heng ^a,b   Wan, De Sen ^a,b   Pan, Zhi Zhong ^a,b  

^a SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

^b SUN YAT SEN UNIVERSITY   (China)

Author keywords

Colon cancer; Neutrophil to lymphocyte ratio; Stage IIA

Indexed keywords

ADULT; AGED; ARTICLE; BLOOD CELL COUNT; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; COLON CANCER; COLON RESECTION; FEMALE; HUMAN; LYMPH NODE; MAJOR CLINICAL STUDY; MALE; NEUTROPHIL TO LYMPHOCYTE RATIO; PREOPERATIVE PERIOD; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; SURVIVAL RATE; SURVIVAL TIME;

ADULT; AGED; AGED, 80 AND OVER; BLOOD CELL COUNT; COLONIC NEOPLASMS; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; LYMPHOCYTES; MALE; MIDDLE AGED; NEOPLASM STAGING; NEUTROPHILS; PREDICTIVE VALUE OF TESTS; RECURRENCE; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 78149406896     PISSN: 01791958     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00384-010-1052-0     Document Type: Article

References (31)

1. S Gill CL Loprinzi DJ Sargent SD Thome, et al. 2004 Pooled analysis of fluorouracil-based adjuvant therapy for stage II and III colon cancer: who benefits and by how much? J Clin Oncol 22 10 1797 1806 1:CAS:528: DC%2BD2cXptlClu7Y%3D 10.1200/JCO.2004.09.059 15067028 (Pubitemid 41095169)
2. G Quasar Collaborative R Gray J Barnwell C McConkey, et al. 2007 Adjuvant chemotherapy versus observation in patients with colorectal cancer: a randomised study Lancet 370 9604 2020 2029 10.1016/S0140-6736(07)61866-2 (Pubitemid 350236339)
3. W Schippinger H Samonigg R Schaberl-Moser R Greil, et al. 2007 A prospective randomised phase III trial of adjuvant chemotherapy with 5-fluorouracil and leucovorin in patients with stage II colon cancer Br J Cancer 97 8 1021 1027 1:CAS:528:DC%2BD2sXhtFKktb7N 10.1038/sj.bjc.6604011 17895886 (Pubitemid 47587021)
4. F Cianchi L Messerini CE Comin V Boddi, et al. 2007 Pathologic determinants of survival after resection of T3N0 (Stage IIA) colorectal cancer: proposal for a new prognostic model Dis Colon Rectum 50 9 1332 1341 10.1007/s10350-007-0222-9 17429709 (Pubitemid 47472384)
5. AB Benson D Schrag MR Somerfield AM Cohen, et al. 2004 American society of clinical oncology recommendations on adjuvant chemotherapy for stage II colon cancer J Clin Oncol 22 16 3408 3419 10.1200/JCO.2004.05.063 15199089 (Pubitemid 41103700)
6. SR Walsh EJ Cook F Goulder TA Justin, et al. 2005 Neutrophil-lymphocyte ratio as a prognostic factor in colorectal cancer J Surg Oncol 91 3 181 184 1:STN:280:DC%2BD2MvlvFCjtA%3D%3D 10.1002/jso.20329 16118772 (Pubitemid 41254421)
7. KJ Halazun A Aldoori HZ Malik A Al-Mukhtar, et al. 2008 Elevated preoperative neutrophil to lymphocyte ratio predicts survival following hepatic resection for colorectal liver metastases Eur J Surg Oncol 34 1 55 60 1:STN:280:DC%2BD2sjlvFKksw%3D%3D 17448623
8. Y Kishi S Kopetz YS Chun M Palavecino, et al. 2009 Blood neutrophil-to-lymphocyte ratio predicts survival in patients with colorectal liver metastases treated with systemic chemotherapy Ann Surg Oncol 16 3 614 622 10.1245/s10434-008-0267-6 19130139
9. American Joint Committee on Cancer (2002) AJCC cancer staging manual, 6th edn. Springer-Verlag, New York
10. JB O'Connell MA Maggard CY Ko 2004 Colon cancer survival rates with the new American joint committee on cancer sixth edition staging J Natl Cancer Inst 96 19 1420 1425 10.1093/jnci/djh275 15467030 (Pubitemid 39429665)
11. KM Sarraf E Belcher E Raevsky AG Nicholson, et al. 2009 Neutrophil/lymphocyte ratio and its association with survival after complete resection in non-small cell lung cancer J Thorac Cardiovasc Surg 137 2 425 428 10.1016/j.jtcvs.2008.05.046 19185164
12. H Cho HW Hur SW Kim SH Kim, et al. 2009 Pre-treatment neutrophil to lymphocyte ratio is elevated in epithelial ovarian cancer and predicts survival after treatment Cancer Immunol Immunother 58 1 15 23 1:CAS:528: DC%2BD1cXht1yqs7bO 10.1007/s00262-008-0516-3 18414853
13. D Gomez G Morris-Stiff GJ Toogood JP Lodge, et al. 2008 Impact of systemic inflammation on outcome following resection for intrahepatic cholangiocarcinoma J Surg Oncol 97 6 513 518 10.1002/jso.21001 18335453 (Pubitemid 351631430)
14. D Gomez S Farid HZ Malik AL Young, et al. 2008 Preoperative neutrophil-to-lymphocyte ratio as a prognostic predictor after curative resection for hepatocellular carcinoma World J Surg 32 8 1757 1762 1:STN:280:DC%2BD1cvotlegtA%3D%3D 10.1007/s00268-008-9552-6 18340479
15. R Gal E Sadikov J Sulkes B Klein, et al. 2004 Deleted in colorectal cancer protein expression as a possible predictor of response to adjuvant chemotherapy in colorectal cancer patients Dis Colon Rectum 47 7 1216 1224 10.1007/s10350-004-0552-9 15148649
16. E Dotor M Cuatrecases M Martinez-Iniesta M Navarro, et al. 2006 Tumor thymidylate synthase 1494del6 genotype as a prognostic factor in colorectal cancer patients receiving fluorouracil-based adjuvant treatment J Clin Oncol 24 10 1603 1611 1:CAS:528:DC%2BD28XjvFykt7Y%3D 10.1200/JCO.2005.03.5253 16575011 (Pubitemid 46638784)
17. JL Westra M Schaapveld H Hollema JP de Boer, et al. 2005 Determination of TP53 mutation is more relevant than microsatellite instability status for the prediction of disease-free survival in adjuvant-treated stage III colon cancer patients J Clin Oncol 23 24 5635 5643 1:CAS:528:DC%2BD2MXhtVersrzN 10.1200/JCO.2005.04.096 16110022
18. CM Ribic DJ Sargent MJ Moore SN Thibodeau, et al. 2003 Tumor microsatellite-instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for colon cancer N Engl J Med 349 3 247 257 1:CAS:528:DC%2BD3sXlsVGjsbY%3D 10.1056/NEJMoa022289 12867608 (Pubitemid 36859476)
19. A Barrier PY Boelle F Roser J Gregg, et al. 2006 Stage II colon cancer prognosis prediction by tumor gene expression profiling J Clin Oncol 24 29 4685 4691 1:CAS:528:DC%2BD28XhtFynsr3N 10.1200/JCO.2005.05.0229 16966692 (Pubitemid 46630932)
20. YH Uen CY Lu HL Tsai FJ Yu, et al. 2008 Persistent presence of postoperative circulating tumor cells is a poor prognostic factor for patients with stage I-III colorectal cancer after curative resection Ann Surg Oncol 15 8 2120 2128 10.1245/s10434-008-9961-7 18481151
21. H Ohtani 2007 Focus on TILs: prognostic significance of tumor infiltrating lymphocytes in human colorectal cancer Cancer Immun 7 4 17311363
22. HE Ownby LD Roi RR Isenberg MJ Brennan 1983 Peripheral lymphocyte and eosinophil counts as indicators of prognosis in primary breast cancer Cancer 52 1 126 130 1:STN:280:DyaL3s3gs1CjsQ%3D%3D 10.1002/1097-0142(19830701)52:1<126: :AID-CNCR2820520123>3.0.CO;2-Y 6850535
23. RM Strieter MD Burdick J Mestas B Gomperts, et al. 2006 Cancer CXC chemokine networks and tumour angiogenesis Eur J Cancer 42 6 768 778 1:CAS:528:DC%2BD28Xjs1GrtL0%3D 10.1016/j.ejca.2006.01.006 16510280
24. KJ Halazun MA Hardy AA Rana DC Woodland, et al. 2009 Negative impact of neutrophil-lymphocyte ratio on outcome after liver transplantation for hepatocellular carcinoma Ann Surg 250 1 141 151 10.1097/SLA.0b013e3181a77e59 19561458
25. RS Swanson CC Compton AK Stewart KI Bland 2003 The prognosis of T3N0 colon cancer is dependent on the number of lymph nodes examined Ann Surg Oncol 10 1 65 71 10.1245/ASO.2003.03.058 12513963
26. R Vather T Sammour K Zargar-Shoshtari P Metcalf, et al. 2009 Lymph node examination as a predictor of long-term outcome in Dukes B colon cancer Int J Colorectal Dis 24 3 283 288 10.1007/s00384-008-0540-y 18716784
27. L Sarli G Bader D Iusco C Salvemini, et al. 2005 Number of lymph nodes examined and prognosis of TNM stage II colorectal cancer Eur J Cancer 41 2 272 279 10.1016/j.ejca.2004.10.010 15661553 (Pubitemid 40126960)
28. FC Wright CH Law L Last M Khalifa, et al. 2003 Lymph node retrieval and assessment in stage II colorectal cancer: a population-based study Ann Surg Oncol 10 8 903 909 1:STN:280:DC%2BD3svmsFGgtg%3D%3D 10.1245/ASO.2003.01.012 14527909 (Pubitemid 40486855)
29. CH Law FC Wright T Rapanos M Alzahrani, et al. 2003 Impact of lymph node retrieval and pathological ultra-staging on the prognosis of stage II colon cancer J Surg Oncol 84 3 120 126 10.1002/jso.10309 14598354 (Pubitemid 37363153)
30. M Tanaka Y Hashiguchi H Ueno K Hase, et al. 2003 Tumor budding at the invasive margin can predict patients at high risk of recurrence after curative surgery for stage II, T3 colon cancer Dis Colon Rectum 46 8 1054 1059 10.1007/s10350-004-7280-z 12907899 (Pubitemid 36992987)
31. LM Wang D Kevans H Mulcahy J O'Sullivan, et al. 2009 Tumor budding is a strong and reproducible prognostic marker in T3N0 colorectal cancer Am J Surg Pathol 33 1 134 141 1:CAS:528:DC%2BD1MXitlajtrs%3D 10.1097/PAS.0b013e3181ad25d5 18971777